Dow Corning Ramps up Pharmaceutical Grade Silicone Tubing Production in Response to Influenza Outbreak
One million feet of tubing to help produce vaccines and anti-viral drugs
Midland, Mich.- In response to an urgent need from a pharmaceutical customer developing flu vaccines and anti-viral drugs to battle potential pandemics, Dow Corning is producing an additional one million feet of pharmaceutical grade silicone tubing designed for critical fluid transport and filling applications necessary for drug and vaccine production.
"As the only global silicone manufacturer involved in each step of the manufacturing process-from processing the raw materials to producing extruded and molded pharmaceutical grade silicone-Dow Corning is in a unique position to rapidly provide reliable, proven tubing," said Carol Pudnos, Dow Corning Healthcare Industry director.
Dow Corning has manufactured products used to meet the stringent requirements of ultra-pure fluid handling for vaccine production for nearly 50 years. The company's silicone tubing and fabricated tubing assemblies are produced with Dow Corning Silastic® BioMedical Grade Elastomers at Dow Corning's FDA-registered Health Industries Materials Site in Hemlock, Michigan.
"Pharmaceutical companies preparing for possible crises face a number of challenges that demand new solutions that help reduce the risk of contamination and improve processing efficiency, often on short notice and in great quantity," said Pudnos.
About Dow Corning
Dow Corning www.dowcorning.com provides performance-enhancing solutions to serve the diverse needs of more than 25,000 customers worldwide. A global leader in silicones, silicon-based technology and innovation, Dow Corning offers more than 7,000 products and services via the company's Dow Corning® and XIAMETER® brands. Dow Corning is a joint venture equally owned by The Dow Chemical Company and Corning, Incorporated. More than half of Dow Corning's annual sales are outside the United States.
Contact:
Jeffrey A. Smith
APCO Worldwide
202-778-2012
jsmith@apcoworldwide.com
